Phreesia, Inc.
Phreesia, Inc. provides a SaaS-based patient intake and payment platform for healthcare organizations in the United States. Its products help medical practices and other healthcare services clients register patients, collect payments, and deliver patient communications, while its life sciences offerings support patient engagement and health-related marketing campaigns.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueSaaS tools for patient intake, registration, scheduling-related workflows, and practice operations.
Patient payment facilitation and related transaction fees tied to healthcare visits.
Campaigns and direct communications used by life sciences customers to engage patients.
Products
Reported · share of revenue- Subscription and Services45.7 %
- Network Solutions29.1 %
- Payment Solutions25.3 %
Source: 10-K FY2026, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Phreesia sells primarily to healthcare services organizations such as medical practices and other outpatient providers across the U.S. It also serves life sciences companies, healthcare advertising agencies, government entities, and advocacy groups that use its platform for patient outreach and education. Customer relationships are typically sold through direct sales, with annual auto-renewing contracts common in healthcare services.
Medical practices and other healthcare providers that buy intake, registration, and payment workflow tools to streamline patient visits.
Pharmaceutical and other life sciences organizations that buy patient communications and campaign services to activate and educate patients.
Agencies that purchase or manage patient-facing campaign services on behalf of healthcare and life sciences clients.
Public-sector and advocacy buyers that use Phreesia for targeted health communications and outreach.
Strategy
Phreesia’s strategy centers on expanding adoption of its healthcare workflow platform, increasing use of add-on solutions, and deepening relationships with existing clients through onboarding, training, and support. It also uses direct sales and marketing to grow life sciences campaigns and to retain customers through annual renewals and land-and-expand selling.
Broader product adoption raises account value and supports retention.
Faster go-live and smoother onboarding help win and retain accounts.
Campaign-based offerings broaden the customer base beyond providers.
Geography
Phreesia focuses substantially all of its sales efforts within the United States, and substantially all of its historical revenue has come from the U.S. The company also has employees in non-U.S. jurisdictions such as Canada and India, which affects operating support and compliance exposure, but the commercial footprint remains overwhelmingly domestic.
Risks
Phreesia operates in a competitive healthcare technology market where it must integrate with EHR and practice management systems and keep pace with changing client needs and AI-enabled products. Its business also depends on third-party hardware suppliers and contract manufacturers, while revenue concentration in the U.S. ties performance to domestic healthcare regulation, customer budgets, and adoption cycles.
- Competitive pressure from integrated healthcare software vendorsImpact: HighLikelihood: Medium
Customers may prefer bundled EHR/PM solutions or lower-cost alternatives.
Exposure: Healthcare services platform
- Supplier concentration for PhreesiaPad and Arrivals KiosksImpact: HighLikelihood: Medium
A sole or limited supplier base can disrupt hardware availability and client deployments.
Exposure: Hardware-enabled patient intake solutions
- Regulatory and compliance change in U.S. healthcareImpact: MediumLikelihood: Medium
Product workflows and patient communications must adapt to changing rules.
Exposure: Healthcare data and patient engagement
- Customer renewal and sales-cycle riskImpact: MediumLikelihood: Medium
Annual auto-renewing contracts and competitive sales processes can delay growth.
Exposure: Healthcare services and life sciences contracts
- Technology obsolescence and AI-driven competitionImpact: MediumLikelihood: Medium
Rapid product innovation could weaken differentiation if Phreesia does not keep pace.
Exposure: Software platform and patient engagement tools
Accounting
Judgemental itemsDifferent offerings have different performance obligations and timing of recognition under ASC 606.
Impact: Affects reported revenue mix and quarterly comparability
Development costs are capitalized and amortized, affecting expense timing and asset balances.
Impact: Can shift operating costs between periods
Acquired assets and liabilities must be measured at fair value, including intangibles and goodwill.
Impact: Can create future impairment risk and affect amortization
Customer collections and credit quality influence receivable reserves.
Impact: Impacts net revenue and working capital
Equity awards require valuation assumptions that affect operating expenses.
Impact: Can materially affect reported profitability
Similar listed companies
Publicly listed companies with a comparable business focus.
TruBridge, Inc.
Services-Computer Programming Services
Health Catalyst, Inc.
HCAT · Services-Computer Programming, Data Processing, Etc.
Health Catalyst builds cloud-based data and analytics software for healthcare organizations, combining a data platform, analytics applications, and implementation expertise.
Healthcare Triangle, Inc.
HCTI · Services-Computer Integrated Systems Design
Preaxia Health Care Payment Systems Inc.
PAXH · Retail-Home Furniture, Furnishings & Equipment Stores
IQVIA Holdings, Inc
IQV · Services-Commercial Physical & Biological Research
Maximus, Inc
MMS · Services-Business Services, NEC
MAXIMUS is a U.S.-based government services contractor that designs and operates tech-enabled programs for federal, state, local, and international public agencies.
Last updated: 24/09/2026